An India-based pharmaceutical company tripled the price of its valsartan after competitors were forced to take theirs off the market.
from USATODAY - News Top Stories http://bit.ly/2SjEBVC
An India-based pharmaceutical company tripled the price of its valsartan after competitors were forced to take theirs off the market.
0 comments:
Post a Comment